Inclusivity testing with the ‘most promising’ beads or bead combinations (50:50 mix or dually coated) to capture three different MAP strains (TB13-008781, TB13-004573, TB12-017632) from PBS dilutions containing from 10⁴−10 cfu/ml.

<p>DNA extracted from the bacterial suspensions before MS was used as a control. The expected IS900 PCR product is 394 bp. Lane MW indicate a 100 bp DNA ladder (TrackIt™, Life Technologies).